P043: Injecting drug users (IDUs) are prone to Hepatitis B because of the high risk behaviour. Hepatitis B can be prevented through vaccines but the IDUs and their sexual partners from Kathmandu, Nepal are not getting preventive hepatitis B vaccinations

2015 ◽  
Vol 22 ◽  
pp. 40-41
Keyword(s):  
High Risk ◽  
Hepatitis B ◽  
Drug Users ◽  
Risk Behaviour ◽  
Injecting Drug Users ◽  
Sexual Partners ◽  
High Risk Behaviour ◽  
Preventive Hepatitis

The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United Kingdom

2019 ◽  
Vol 23 (3) ◽  
pp. 437-445 ◽  
Author(s):  
J Sira ◽  
M Brown ◽  
S Ambegaokar ◽  
L Modin ◽  
DA Kelly
Keyword(s):  
High Risk ◽  
Young People ◽  
Hepatitis B ◽  
Risk Behaviour ◽  
Sexual Partners ◽  
Unprotected Sex ◽  
Hepatitis B Vaccination ◽  
Serological Tests ◽  
High Risk Behaviour ◽  
Reported Data

Blood borne virus (BBV) infection in adults involved in high risk behaviour is well recognized. There are limited reported data on young people involved in high risk behaviour. A descriptive questionnaire was used to ascertain risk behaviour at the Young People’s Substance Misuse Service (Birmingham). Data collection included risk behaviour and serological tests for hepatitis B, C and HIV. Sixty-five of one-hundred three (63%) young people participated; 37/65 male; age range 13.9–18.9 (median 17.4 years). Risk behaviour included 6 intravenous drug, 58 cannabis, and 61 had sexual partners, of whom 52 (85%) engaged in unprotected sex. Sixty-five participants were negative for BBV infection: 9 were HBV immune. HB vaccination was not available at the centre (for <18 year), and all refused referral to their general practitioner for vaccination due to fear of disclosure. The main risk for BBV acquisition was unprotected sex with multiple sexual partners and illicit drug use. Most were unaware of the risks related to high risk behaviour. Effective education programmes of relevant risk factors with HBV vaccination should be implemented during preadolescence. We recommend an integrated service via specialized centres, to work together to improve awareness and increase efforts to vaccinate adolescents at risk for HBV infection.

scholarly journals High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia

2007 ◽  
Vol 18 (1) ◽  
pp. 41-46 ◽  
Author(s):  
Anneli Uusküla ◽  
Louise Anne McNutt ◽  
Jack Dehovitz ◽  
Krista Fischer ◽  
Robert Heimer
Keyword(s):  
High Risk ◽  
Drug Users ◽  
Risk Behaviour ◽  
Injecting Drug Users ◽  
Virus Infections ◽  
High Prevalence ◽  
High Risk Behaviour

scholarly journals Character and High Risk Behaviour of Drug Addicts for Spreading Hepatitis B and HIV Infection in a Selected Area of Dhaka City

2014 ◽  
Vol 9 (1) ◽  
pp. 35-42 ◽  
Author(s):  
M Hakim ◽  
M Ahmad ◽  
S Naher ◽  
M Ali ◽  
MU Ahmed
Keyword(s):  
High Risk ◽  
Hepatitis B ◽  
Drug Addiction ◽  
Addiction Treatment ◽  
Family Income ◽  
Risk Behaviour ◽  
Armed Forces ◽  
Drug Abusers ◽  
Drug Addicts ◽  
High Risk Behaviour

Introduction: The number of drug abusers is increasing in an alarming state in Bangladesh and they are identified as high risk group for developing Hepatitis B and HIV. Objectives: The aim of this study was to find out various information about drug addicts and their behavioural pattern which can guide the future developmental strategies and planning for reduction of spreading hepatitis B and HIV among the vulnerable population. Methods: This descriptive type of cross sectional study was performed during July 2006 to June 2007 in three different drug addiction treatment clinic in Uttara, Dhaka on high risk behaviour of drug addicts . A total 194 Drug addicts were interviewed individually by using a structured questionnaire. The questionnaire was filled up by the author during interview. All the data were checked and edited after collection on the spot. Compilation and subsequent tabulation were done manually. Simple technique of data analysis for percentage, average, standard deviations etc. were done with scientific calculator and using SPSS 11. Results: Out of 194 cases 180 (92.78%) were male and 114(58.76%) were unmarried. Most of them 118(60.82%) were within the age group of 20 to 29 years. They have an average family income of 12456.39 Taka per month. Most of the addicts 73(37.63%) were students.Average family size of drug addicts were 6.73 and majority of them 148(76.29%) resided with parents. Only 16(8.24%) drug addicts expressed quarrelsome relationship among their parents and 21(10.83%) stated a bad relationship with other family members. Of them 86(44.33%) started to have taking drug at an age range between 20 to 29 years and most of them 156(80.41%) used poly drug.Heroin 161(82.99%) ranked top as abused drug. Most of them 143(73.71%) were influenced by their friends for initiation of drug addiction. The average daily expense for drug was 191.13 Taka per day and most of them 142(73.19%) had frequency of drug abuse more than once daily. Only 20(10.31%) were found as Intravenous Drug Users (IDU); 16(80%) of the IDUs shared same syringe/needle.Among all the addicts 6(3.09%) were professional blood donor and among the IDU 4(20%) were professional blood donors. 139(71.65%) had history of sex without condom. 82(42.27%) were unaware about high risk behaviour due to lack of adequate knowledge. 185(95.36%) used to procure drug from black market. 5(25%) of IDU and 2(1.15%) of non IDU were found to be Hepatitis B positive though no HIV positive case was found. Conclusion: Wide spread motivation of the drug addicts and nationwide publicity regarding the ill effects of their high risk behaviour are needed to combat the spread of Hepatitis B/ HIV. DOI: http://dx.doi.org/10.3329/jafmc.v9i1.18723 Journal of Armed Forces Medical College Bangladesh Vol.9(1) 2013: 35-42

Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal

2016 ◽  
Vol 33 ◽  
pp. 75-82 ◽  
Author(s):  
Gabriel Loewinger ◽  
Bishnu Sharma ◽  
Deepak Kumar Karki ◽  
Prasana Khatiwoda ◽  
Sher Kainee ◽  
...  
Keyword(s):  
Hepatitis C ◽  
High Risk ◽  
Injection Drug Users ◽  
Drug Users ◽  
Risk Behaviour ◽  
Injection Drug ◽  
High Risk Behaviour

HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow

AIDS Care ◽  
1993 ◽  
Vol 5 (4) ◽  
pp. 413-425 ◽  
Author(s):  
T. J. Rhodes ◽  
M. J. Bloor ◽  
M. C. Donoghoe ◽  
S. Haw ◽  
B. Ettore ◽  
...  
Keyword(s):  
Hiv Risk ◽  
Drug Users ◽  
Risk Behaviour ◽  
Injecting Drug Users ◽  
Hiv Prevalence

Hepatitis B immunity in Australia: a comparison of national and prisoner population serosurveys

2015 ◽  
Vol 143 (13) ◽  
pp. 2813-2821 ◽  
Author(s):  
H. F. GIDDING ◽  
D. MAHAJAN ◽  
J. REEKIE ◽  
A. R. LLOYD ◽  
D. E. DWYER ◽  
...  
Keyword(s):  
High Risk ◽  
General Population ◽  
Hepatitis B ◽  
Drug Users ◽  
Past Infection ◽  
Previous Episode ◽  
Hbv Vaccination ◽  
First Time ◽  
Male Prisoners ◽  
Surface Antibody

SUMMARYIn Australia, hepatitis B (HBV) vaccination is recommended for injecting drug users (IDUs), Indigenous adults and prisoners. We compared immunity to HBV in prisoners and the general population obtained from national serosurveys in 2007. Individuals with HBV surface antibody (HBsAb) positive sera were considered immune from past infection [HBV core antibody (HBcAb) positive] or from vaccination (HBcAb negative). Male prisoners aged 18–58 years had a higher HBsAb seroprevalence than the general population (46·4% vs. 39·4%, P = 0·061). Comparison of HBcAb results was possible for males aged 18–29 years. In this group, higher HBsAb seroprevalence was due to past infection (12·9% vs. 3·0%, P < 0·001), rather than vaccine-conferred immunity (35·3% vs. 43·4%, P = 0·097). All prisoner groups, but especially IDUs, those of Indigenous heritage or those with a previous episode of imprisonment had higher levels of immunity from past infection than the general population (19·3%, 33·0%, 17·1%, respectively, vs. 3·0%, P < 0·05). Indigenous prisoners, non-IDUs and first-time entrants had significantly lower levels of vaccine-conferred immunity than the general population (26·4%, 26·2% and 20·7% respectively vs. 43·4%, P < 0·05). Improving prison-based HBV vaccination would prevent transmission in the prison setting and protect vulnerable members of the community who are at high risk of both infection and entering the prison system.

Sign in / Sign up

Export Citation Format

Share Document